13D/13G Filings - ORBIMED ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...13, 14, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-07-09
8:06 pm
Sale
2025-07-0713DPassage Bio, Inc.
PASG
ORBIMED ADVISORS LLC5,923,534
9.500%
-726,466decrease
(-10.92%)
Filing
History
2025-06-18
8:23 pm
Purchase
2025-06-1413DIkena Oncology, Inc.
IKNA
ORBIMED ADVISORS LLC8,008,913
16.710%
5,819,802increase
(+265.85%)
Filing
History
2025-06-17
5:30 pm
Unchanged
2025-06-1613DEnliven Therapeutics, Inc.
ELVN
ORBIMED ADVISORS LLC7,918,163
13.400%
0
(Unchanged)
Filing
History
2025-05-15
8:15 pm
Unchanged
2025-03-3113GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC3,406,335
10.500%
0
(Unchanged)
Filing
History
2025-05-15
8:13 pm
Unchanged
2025-03-3113GInspireMD, Inc.
NSPR
ORBIMED ADVISORS LLC2,133,405
7.200%
0
(Unchanged)
Filing
History
2025-05-15
8:09 pm
Purchase
2025-03-3113GC4 Therapeutics, Inc.
CCCC
ORBIMED ADVISORS LLC4,655,600
6.600%
4,655,600increase
(New Position)
Filing
History
2025-05-15
6:46 pm
Purchase
2025-03-3113GWhitehawk Therapeutics Inc
WHWK
ORBIMED ADVISORS LLC4,166,000
8.900%
4,166,000increase
(New Position)
Filing
History
2025-05-15
6:41 pm
Sale
2025-03-3113GVerastem, Inc.
VSTM
ORBIMED ADVISORS LLC2,862,448
5.600%
-1,286,414decrease
(-31.01%)
Filing
History
2025-05-14
8:49 pm
Unchanged
2025-05-1213DCorvus Pharmaceuticals, Inc.
CRVS
ORBIMED ADVISORS LLC9,785,423
12.200%
0
(Unchanged)
Filing
History
2025-05-12
7:13 pm
Purchase
2025-05-0913DEdgewise Therapeutics, Inc.
EWTX
ORBIMED ADVISORS LLC15,252,867
14.500%
496,771increase
(+3.37%)
Filing
History
2025-05-01
9:20 pm
Purchase
2025-04-2913DCorvus Pharmaceuticals, Inc.
CRVS
ORBIMED ADVISORS LLC9,785,423
13.800%
2,841,769increase
(+40.93%)
Filing
History
2025-04-25
7:48 pm
Sale
2025-04-2213DPassage Bio, Inc.
PASG
ORBIMED ADVISORS LLC6,650,000
10.700%
-754,869decrease
(-10.19%)
Filing
History
2025-04-14
7:09 pm
Sale
2025-04-1013DXtant Medical Holdings, Inc.
XTNT
ORBIMED ADVISORS LLC0
0.000%
-73,114,592decrease
(Position Closed)
Filing
History
2025-04-11
7:21 pm
Sale
2024-04-0913DCompass Therapeutics, Inc.
CMPX
ORBIMED ADVISORS LLC15,219,994
11.000%
-3,571,428decrease
(-19.01%)
Filing
History
2025-03-12
7:57 pm
Sale
2025-03-1013DDisc Medicine, Inc.
IRON
ORBIMED ADVISORS LLC1,556,369
4.500%
-229,202decrease
(-12.84%)
Filing
History
2025-02-14
4:35 pm
Purchase
2024-12-3113GADC Therapeutics S.A.
ADCT
ORBIMED ADVISORS LLC3,437,813
3.600%
3,437,813increase
(New Position)
Filing
History
2025-02-14
4:32 pm
Purchase
2024-12-3113GRAPT Therapeutics, Inc.
RAPT
ORBIMED ADVISORS LLC13,135,260
9.900%
13,135,260increase
(New Position)
Filing
History
2025-02-14
4:30 pm
Purchase
2024-12-3113GCorbus Pharmaceuticals Holdings, Inc.
CRBP
ORBIMED ADVISORS LLC718,200
5.900%
129,000increase
(+21.89%)
Filing
History
2025-02-14
4:22 pm
Purchase
2024-12-3113GForte Biosciences, Inc.
FBRX
ORBIMED ADVISORS LLC510,000
8.000%
510,000increase
(New Position)
Filing
History
2025-02-13
4:47 pm
Purchase
2025-02-1013DSionna Therapeutics, Inc.
SION
ORBIMED ADVISORS LLC3,704,959
8.400%
3,704,959increase
(New Position)
Filing
History
Goto 0, 1, 2, ...13, 14, Next